Clinical trial
Biological Therapy and Gene Therapy in Treating Children With Recurrent or…
NCT00006480 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00006480 |
|---|---|
| Title | Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma |
| Official title | Phase I Study to Evaluate the Safety of Cellular Immunotherapy for Recurrent/Refractory Neuroblastoma Using Genetically-Modified Autologous CD8+ T Cell Clones |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neuroblastoma |
| Intervention type | Biological, Drug |
| Interventions | aldesleukin, therapeutic autologous lymphocytes, chemotherapy, ganciclovir |
| Start date | May 1, 2000 |
| Completion | Mar 1, 2005 |
| First posted | Dec 31, 2003 |
| Last update posted | Sep 21, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: